This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Icagen to Present at Eighth Annual Bio Investor Forum 2009-10-20 08:15 ET - News Release RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Eighth Annual BIO Investor Forum to be held October 28 through October 29, 2009 at the Palace Hotel in San Francisco, CA. Management is scheduled to present an overview of the company and research and development programs at 3:00 p.m. PDT on Thursday, October 29, 2009.
To listen to the audio web cast of the presentation during or after the event, please visit www.icagen.com. An archive of the presentation will be available for replay for approximately 90 days.
About Icagen
Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels. The Company is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. The Company has clinical stage programs in epilepsy and asthma.
The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page